Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial - Concepedia

Concepedia

Publication | Open Access

Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial

DOI Full Paper Access

26

Citations

35

References

2013

Year

Marshall J. Glesby, Jeanine Albu, Ya‐Lin Chiu, Kirsis Ham, Ellen S. Engelson, Qing He, Varalakshmi Muthukrishnan, Henry N. Ginsberg, Daniel Donovan, Jerry Ernst,

Abstract

Clinicaltrials.gov NCT00130286.

References

	Year	Citations

Page 1